- Details
- Written by Department of Justice
- Category: News
Detroit, Michigan - IAV GmbH (IAV), a German company that engineers and designs automotive systems, has agreed to plead guilty to one criminal felony count and pay a $35 million criminal fine as a result of the company’s role in a long-running scheme for Volkswagen AG (VW) to sell diesel vehicles in the United States by using a defeat device to cheat on U.S. vehicle emissions tests required by federal law.
- Details
- Written by IVN
- Category: News
Washington, DC - Acting Attorney General Matthew Whitaker announced that the Department of Justice has amended the regulations of the Bureau of Alcohol, Tobacco, Firearms, and Explosives (ATF), clarifying that bump stocks fall within the definition of “machinegun” under federal law, as such devices allow a shooter of a semiautomatic firearm to initiate a continuous firing cycle with a single pull of the trigger.
- Details
- Written by IVN
- Category: News
Miami, Florida - A Miami, Florida-area woman was sentenced to 78 months in prison to be followed by three years of supervised release Monday for her role in a $4.65 million health care fraud scheme involving three home health agencies that purported to provide home health services to Medicare patients.
- Details
- Written by White House
- Category: News
Bethesda, Maryland, Walter Reed Medical Center -Vice President Pence Visiting the USO Warrior and Family Center:
- Details
- Written by Amanda Turney
- Category: News
Washington, DC - “As part of FDA’s strategy to continue to encourage the modernization of clinical trials, we’re providing new recommendations for drug developers regarding the most effective clinical trial endpoints to help advance the development of products to treat cancer. Over the past several decades, we’ve seen an evolution in cancer care in how treatment effect is measured, and which endpoints are successful measures of disease activity or clinical benefit to patients. As part of these advances, there’s been a robust debate about the use of surrogate endpoints to support both traditional and accelerated approvals. We’ve engaged patient and health care professional communities to inform our regulatory decision-making around these issues, to ensure we are keeping pace with the science and continuing to encourage development of treatments that offer meaningful results for patients,” said FDA Commissioner Scott Gottlieb, M.D.
- Details
- Written by White House
- Category: News
Washington, DC - "We have been working every day to deliver for America’s farmers just as they work every single day to deliver for us." ~ President Donald J. Trump
Subcategories
Page 724 of 1259
- You are here:
-
Home
-
News
-
Health News
- News